Akero Therapeutics Inc (AKRO)

21.13 -1.05  -4.73% NASDAQ Nov 26, 16:00 USD

Akero Therapeutics Cash from Financing (TTM):

0.418M for Sept. 30, 2021
View 4,000+ financial data types
View Full Chart

Cash from Financing (TTM) Chart

Export Data
Save Image
Print Image

Historical Cash from Financing (TTM) Data

View and export this data going back to 2018. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2021 0.418M
June 30, 2021 203.13M
March 31, 2021 202.97M
Dec. 31, 2020 203.11M
Sept. 30, 2020 203.16M
June 30, 2020 -1.228M
March 31, 2020 96.87M
Dec. 31, 2019 95.99M
Sept. 30, 2019 166.10M
June 30, 2019 167.70M
March 31, 2019 84.29M
Dec. 31, 2018 85.01M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.


Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Benchmarks

NovaBay Pharmaceuticals Inc 1.999M
Palatin Technologies Inc -0.2182M
iBio Inc 42.65M

Cash from Financing (TTM) Range, Past 5 Years

Minimum -1.228M Jun 2020
Maximum 203.16M Sep 2020
Average 125.63M


Insider Sell: Akero Therapeutics
MT Newswires 11/05 16:58 ET
Insider Sell: Akero Therapeutics
MT Newswires 11/03 17:56 ET
MIME, LBTYA and PTEN among after hour movers
SA Breaking News 10/19 17:43 ET
Insider Sell: Akero Therapeutics
MT Newswires 10/18 17:05 ET
Insider Sell: Akero Therapeutics
MT Newswires 10/05 16:42 ET



Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.